Piper Sandler sets a price target of $16 for NASDAQ:ARDX, indicating a potential increase of approximately 71.43%.Wall Street analysts project an average price target with a potential upside of 92.1%, reflecting optimism about ARDX's future performance.The stock has experienced a 3.6% increase over the past four weeks, with analysts' short-term price targets ranging from $8 to $16.Ardelyx, Inc. (NASDAQ:ARDX) is a biopharmaceutical company focused on developing innovative therapies for unmet medical needs. T ...